BIND THERAPEUTICS, INC.Waiver of Director Compensation • August 7th, 2014 • BIND Therapeutics, Inc • Pharmaceutical preparations
This letter agreement confirms the understanding of BIND Therapeutics, Inc. (the “Company”) that you desire to waive all compensation payable to you by the Company for your service as a member of the Company’s board of directors (the “Board”) or any committee of the Board during the period commencing on the closing date of the initial public offering of the Company’s capital stock and ending on the date you provide written notice of revocation to the Company as set forth below (the “Waiver Period”). Consequently, the Company will not pay to you, and you will not be entitled to receive, any compensation for your services as a member of the Board or any committee of the Board during the Waiver Period, whether in cash, equity or property and whether under the Company’s non-employee director compensation program or otherwise. You may revoke the foregoing waiver at any time by delivering written notice of revocation to the Company’s Chief Financial Officer, provided that any such revocation
FIRST AMENDMENT TO LEASELease • August 7th, 2014 • BIND Therapeutics, Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 26 day of June, 2014, by and between BMR-325 VASSAR STREET LLC, a Delaware limited liability company (“Landlord”), and BIND THERAPEUTICS, INC., a Delaware corporation (“Tenant,” formerly known as Bind Biosciences, Inc.).
